As one glitch after another at Covid vaccine suppliers upends deliveries, the German federal government is drawing up plans to build up production within its borders...
A few weeks ago, Novartis said it was exploring ways to participate in the European Covid-19 vaccine manufacturing effort. In the meantime, it has been busy. On Mar. 4...
German biotech CureVac has begun a rolling submission with the European Medicines Agency (EMA) for its mRNA-based Covid-19 vaccine candidate currently in Phase 2b/3...
Conventional drugmakers are now responding in force to the Covid-19 vaccine challenge, teaming up on different projects with different partners, contributing expertise...
Vaccines and treatments for Covid-19 continue to dominate global pharma market headlines. As the pandemic drags on, new issues continuously arise, some of them...
Members of the European Parliament (EP) at a Jan. 19 plenary debate on the EU’s strategy for Covid-19 vaccine procurement and deployment for the most part expressed...
CureVac has agreed a collaboration with Bayer to speed up production and distribution of its Covid-19 vaccine candidate CVnCOV, which began clinical trials in December...
French family-owned CDMO Fareva has signed on to handle fill and finish manufacturing for German biotech CureVac’s mRNA-based Covid-19 vaccine candidate, CVnCoV, at the...
